The FDA decided to approve the new diet drug originally known as Qnexa. It gives obese and overweight patients a new weight loss option that does not involve surgery. It will now be called Qsymia. Over four thousand people tested the drug in clinical trials, and more than half lost ten percent of their body weight. Qsymia is actually a combination of two drugs: phentermine, an appetite suppressant, and topiramate, an anti-seizure drug. But there are still some concerns. Some doctors are concerned widespread use of the diet drug could lead to birth defects because topiramate has been shown to increase the risk for cleft lip and palate as well as an increased heart rate in some people. Women of childbearing age who are prescribed Qsymia will be strongly urged to take birth control.
Copyright 2012 KCBD. All rights reserved.